Frequency of circulating mMDSCs in CHB patients.
- Feifei Yang (334047)
- Xueping Yu (14598)
- Chenliang Zhou (703028)
- Richeng Mao (381469)
- Mengqi Zhu (341589)
- Haoxiang Zhu (381465)
- Zhenxuan Ma (6612890)
- Bidisha Mitra (3919016)
- Gan Zhao (4789428)
- Yuxian Huang (381470)
- Haitao Guo (276341)
- Bin Wang (30851)
- Jiming Zhang (381471)
Publication date
April 2019
DOI Publisher
Public Library of Science (PLoS)Abstract
(A) Sequential gating strategy for mMDSC identification (HLA-DR-/low CD33+CD11b+CD14+) from PBMCs. (B) Representative data plots of mMDSCs from CHB patients in different disease phase including IT, IA+, IC and IA-. The boxed areas represent the mMDSCs in PBMCs. (C) Statistical analysis of mMDSCs frequency in PBMCs and (D) in CD14+ monocytes from CHB patients and healthy controls. (E) The numbers of mMDSCs in PBMCs from CHB patients and healthy controls. (F) Comparison of mMDSCs frequency in PBMCs and (G) in CD14+ monocytes from CHB patients in different disease phase. (H) The numbers of mMDSCs in PBMCs from CHB patients. Horizontal lines and error bars represent mean ± SEM.</p
Add to ORKG